Remove company evoke
article thumbnail

Medable Introduces AI to Speed up Standard Trial Timelines

PM360

This year, RPC announced that they had given patients and caregivers over $13 million dollars since the company was founded in 2013. For 2024, we look forward to continuing to connect patients and family caregivers with study opportunities in which they can share their insights and experiences with researchers and companies.”

Media 52
article thumbnail

Saluda Medical Receives FDA Approval for Evoke® System MRI Labeling

Legacy MEDSearch

. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies, today announced that the U.S. The Evoke ® system’s MRI labeling is one of the most comprehensive in the SCS space.

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Dear FDA: WTF?

World of DTC Marketing

Good brand names evoke positive associations and emotional connections with customers. Some patients love the brand of prescription drugs they take because simply “they work” Pharma companies do study brand names, but that’s only about the overall branding of the product. In other words, they resonate.

FDA 180
article thumbnail

The PM360 Trailblazer Awards 2023 Winners

PM360

Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Advancing Breast Cancer Health Equity at the Point of Care” (Susan G.

Education 122
article thumbnail

CNM-Au8 could address vision problems in multiple sclerosis

Pharmaceutical Technology

The main endpoints of the Phase II trial are to investigate visual functions and neurological functions (such as measures of visual function, visual evoked potential, changes in the MS functional composite) induced by remyelination and neuroprotection of the brain and spinal cord.

article thumbnail

PM360 Announces 2023 Trailblazer Award Finalists

PM360

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences.

article thumbnail

PM360 Announces Winners of 2022 Trailblazer Awards

PM360

The awards recognize outstanding companies, CEOs, products, marketers, brand managers, and cutting-edge initiatives within the pharmaceutical, biotech, medical device, and diagnostics industries. COMPANY OF THE YEAR: PHARMACEUTICAL/BIOTECH. COMPANY OF THE YEAR: MEDICAL DEVICE/DIAGNOSTICS. COMPANY OF THE YEAR: ADVERTISING AGENCY.